| scholarly article | Q13442814 |
| P2093 | author name string | Berna C Özdemir | |
| Gian-Paolo Dotto | |||
| P2860 | cites work | Finding the missing heritability of complex diseases | Q22122198 |
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| Ethnic disparity in the relationship between obesity and plasma insulin-like growth factors: the multiethnic cohort | Q24318569 | ||
| Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer | Q24614511 | ||
| Mutations in GNA11 in uveal melanoma | Q24625723 | ||
| Helminth infections: the great neglected tropical diseases | Q24648324 | ||
| Oncogenic mutations in GNAQ occur early in uveal melanoma | Q24658558 | ||
| Oculocutaneous Albinism and Squamous Cell Carcinoma of the Skin of the Head and Neck in Sub-Saharan Africa | Q26782741 | ||
| Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer | Q27851410 | ||
| Cancer-related inflammation | Q27860907 | ||
| Type, density, and location of immune cells within human colorectal tumors predict clinical outcome | Q28131662 | ||
| Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults | Q28131763 | ||
| A melanocortin 1 receptor allele suggests varying pigmentation among Neanderthals | Q28254945 | ||
| The future of immune checkpoint therapy | Q28259862 | ||
| Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms | Q28260472 | ||
| Fat, fibre and cancer risk in African Americans and rural Africans | Q28261264 | ||
| Expression differences between African American and Caucasian prostate cancer tissue reveals that stroma is the site of aggressive changes | Q28292423 | ||
| Evolutionary constraint and disease associations of post-translational modification sites in human genomes | Q28543059 | ||
| The phenotypic legacy of admixture between modern humans and Neandertals | Q28603615 | ||
| African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping | Q28748891 | ||
| Current Issues in Randomized Clinical Trials of Neurodegenerative Disorders at Enrolment and Reporting: Diagnosis, Recruitment, Representativeness of Patients, Ethnicity, and Quality of Reporting | Q30248763 | ||
| HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer | Q30837184 | ||
| Differences in the tumor microenvironment between African-American and European-American breast cancer patients | Q33410258 | ||
| Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas | Q33688915 | ||
| Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men | Q33702311 | ||
| Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population | Q33833942 | ||
| Identification of differentially expressed genes in breast tumors from African American compared with Caucasian women | Q33975072 | ||
| Copy number and gene expression differences between African American and Caucasian American prostate cancer | Q34035973 | ||
| A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER) | Q34041754 | ||
| Genetic Adaptation and Neandertal Admixture Shaped the Immune System of Human Populations | Q34047556 | ||
| Sexual dimorphism in cancer | Q38808593 | ||
| Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study | Q39605778 | ||
| TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients | Q39833035 | ||
| Colorectal Tumors From Different Racial and Ethnic Minorities Have Similar Rates of Mismatch Repair Deficiency. | Q39862222 | ||
| Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities | Q39972544 | ||
| Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location | Q40006369 | ||
| Prevalence of Obesity Among Adults and Youth: United States, 2011-2014. | Q40246125 | ||
| Prognostic Impact of Primary Tumor Location on Clinical Outcomes of Metastatic Colorectal Cancer Treated With Cetuximab Plus Oxaliplatin-Based Chemotherapy: A Subgroup Analysis of the JACCRO CC-05/06 Trials. | Q40447707 | ||
| Genetic Ancestry and Natural Selection Drive Population Differences in Immune Responses to Pathogens | Q40494104 | ||
| Racial Differences in BRAF/KRAS Mutation Rates and Survival in Stage III Colon Cancer Patients | Q40752079 | ||
| Systemic lupus erythematosus and malignancies risk | Q41441163 | ||
| Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States | Q41587976 | ||
| Detection of BRAF mutation in Chinese tumor patients using a highly sensitive antibody immunohistochemistry assay | Q41857360 | ||
| Distinct genomic alterations in prostate cancers in Chinese and Western populations suggest alternative pathways of prostate carcinogenesis. | Q42089044 | ||
| Beyond Red Hair and Sunburns: Uncovering the Molecular Mechanisms of MC1R Signaling and Repair of UV-Induced DNA Damage | Q42226376 | ||
| African ethnicity can influence immunological responses to highly active antiretroviral therapy and immunological success at 48 months: a retrospective pilot study | Q42261360 | ||
| Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women | Q42510389 | ||
| Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C. | Q42608962 | ||
| Black patients with chronic hepatitis C have a lower sustained viral response rate than non-Blacks with genotype 1, but the same with genotypes 2/3, and this is not explained by more frequent dose reductions of interferon and ribavirin*. | Q42999426 | ||
| Impact of Hispanic or Asian ethnicity on the treatment outcomes of chronic hepatitis C: results from the WIN-R trial | Q43039666 | ||
| Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma | Q43572717 | ||
| Insulin resistance and associated compensatory responses in african-american and Hispanic children | Q44231040 | ||
| Strategies for reducing colorectal cancer among blacks | Q44245030 | ||
| MDM2 and CDKN1A gene polymorphisms and risk of Kaposi's sarcoma in African and Caucasian patients | Q44248155 | ||
| Tumor immunobiological differences in prostate cancer between African-American and European-American men. | Q44513168 | ||
| Enhancement of BRCA1 gene expression by the peroxisome proliferator-activated receptor gamma in the MCF-7 breast cancer cell line | Q44559508 | ||
| Estrogen receptor/progesterone receptor-negative breast cancers of young African-American women have a higher frequency of methylation of multiple genes than those of Caucasian women | Q44812865 | ||
| HER2 aberrations in cancer: implications for therapy | Q44936056 | ||
| Impact of race/ethnicity on molecular pathways in human cancer | Q46566449 | ||
| Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups | Q46576514 | ||
| EGFR mutations in US Hispanic versus non-Hispanic white patients with lung adenocarcinoma | Q47797140 | ||
| Impact of race in a predominantly African-American population of patients with low/intermediate risk prostate cancer undergoing radical prostatectomy within an equal access care institution | Q48265908 | ||
| Role of human papillomavirus infection and other factors in patients with head and neck squamous cell carcinoma. | Q51877966 | ||
| Genetic alterations of APC, K-ras, p53, MSI, and MAGE in Korean colorectal cancer patients. | Q53564426 | ||
| Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period. | Q53842386 | ||
| Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort. | Q54357561 | ||
| The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS. | Q54497216 | ||
| Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma. | Q54549143 | ||
| Was skin cancer a selective force for black pigmentation in early hominin evolution? | Q55057722 | ||
| Virologic Response Differences Between African Americans and European Americans Initiating Highly Active Antiretroviral Therapy With Equal Access to Care | Q57419265 | ||
| Ethnic differences in drug metabolism and toxicity from chemotherapy | Q61828192 | ||
| Racial disparity in the association of p53 gene alterations with breast cancer survival | Q72611070 | ||
| Racial differences in insulin secretion and sensitivity in prepubertal children: role of physical fitness and physical activity | Q73165960 | ||
| Kinase mutations and imatinib mesylate response for 64 Taiwanese with advanced GIST: preliminary experience from Chang Gung Memorial Hospital | Q79462936 | ||
| KIT and PDGFRalpha mutations in 104 patients with gastrointestinal stromal tumors (GISTs): a population-based study | Q80475925 | ||
| Investigation of V600E BRAF mutation in papillary thyroid carcinoma in the Polish population | Q80785823 | ||
| Meta-analysis of the association between P53 codon 72 polymorphisms and gastric cancer | Q84780617 | ||
| Hispanic mortality paradox: a systematic review and meta-analysis of the longitudinal literature | Q85910763 | ||
| Intertumor heterogeneity of non-small-cell lung carcinomas revealed by multiplexed mutation profiling and integrative genomics | Q87203816 | ||
| Race and colon cancer survival in an equal-access health care system | Q34086625 | ||
| Correlation of IDH1 mutation with clinicopathologic factors and prognosis in primary glioblastoma: a report of 118 patients from China | Q34146009 | ||
| Cytokine and cytokine receptor genes of the adaptive immune response are differentially associated with breast cancer risk in American women of African and European ancestry | Q34155082 | ||
| Excess of proximal microsatellite-stable colorectal cancer in African Americans from a multiethnic study | Q34204741 | ||
| Evidence for molecular differences in prostate cancer between African American and Caucasian men | Q34205227 | ||
| Oncogenic GNAQ and GNA11 mutations in uveal melanoma in Chinese | Q34287626 | ||
| Adiponectin pathway polymorphisms and risk of breast cancer in African Americans and Hispanics in the Women's Health Initiative | Q34341656 | ||
| The interleukin-6 gene: a susceptibility factor that may contribute to racial and ethnic disparities in breast cancer mortality | Q34378046 | ||
| Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group | Q34546186 | ||
| Ethnic differences in serum adipokine and C-reactive protein levels: the multiethnic cohort | Q34584960 | ||
| CD4(+) T cell count decreases by ethnicity among untreated patients with HIV infection in South Africa and Switzerland | Q34664047 | ||
| Racial differences in chronic immune stimulatory conditions and risk of non-Hodgkin's lymphoma in veterans from the United States | Q34679277 | ||
| Racial diversity of actionable mutations in non-small cell lung cancer | Q35007995 | ||
| Novel recurrently mutated genes in African American colon cancers | Q35038075 | ||
| KRAS and BRAF gene mutations and DNA mismatch repair status in Chinese colorectal carcinoma patients | Q35045790 | ||
| Transcriptomes and shRNA suppressors in a TP53 allele-specific model of early-onset colon cancer in African Americans | Q35152037 | ||
| Patterns of Human Genetic Diversity: Implications for Human Evolutionary History and Disease | Q35550637 | ||
| Genome-wide copy number alterations in subtypes of invasive breast cancers in young white and African American women | Q35573190 | ||
| Population differences in microRNA expression and biological implications | Q35578546 | ||
| Targeted therapies for non-small cell lung cancer: an evolving landscape | Q35628597 | ||
| Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients | Q35693282 | ||
| Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study | Q35815602 | ||
| Cancer Genomics: Diversity and Disparity Across Ethnicity and Geography. | Q35844619 | ||
| Presence of PDGFRA and DOG1 mutations in gastrointestinal stromal tumors among Chinese population | Q35854357 | ||
| Microbiome and Anticancer Immunosurveillance | Q35983760 | ||
| BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinoma in Chinese Patients. | Q35985808 | ||
| Ethnicity-Dependent and -Independent Heterogeneity in Healthy Normal Breast Hierarchy Impacts Tumor Characterization. | Q35999539 | ||
| Racial and ethnic variations in incidence and pattern of malignancies after kidney transplantation | Q36005745 | ||
| Do African-American men need separate prostate cancer screening guidelines? | Q36013706 | ||
| Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. | Q36023488 | ||
| Decreased Anti-Tumor Cytotoxic Immunity among Microsatellite-Stable Colon Cancers from African Americans | Q36054462 | ||
| Genome-wide differentially methylated genes in prostate cancer tissues from African-American and Caucasian men. | Q36213162 | ||
| Ethnicity-specific epigenetic variation in naïve CD4+ T cells and the susceptibility to autoimmunity | Q36318330 | ||
| Intersection of population variation and autoimmunity genetics in human T cell activation | Q36572940 | ||
| Skin cancer in skin of color | Q36628826 | ||
| Assessment of Quantitative and Allelic MGMT Methylation Patterns as a Prognostic Marker in Glioblastoma | Q36648767 | ||
| Humoral immunity, inflammation and cancer | Q36727285 | ||
| Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma | Q36792025 | ||
| Age-specific incidence of breast cancer subtypes: understanding the black-white crossover | Q36806636 | ||
| Racial differences in genome-wide methylation profiling and gene expression in breast tissues from healthy women | Q36833450 | ||
| Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression | Q36885845 | ||
| Cancer Risk in Patients With Inflammatory Systemic Autoimmune Rheumatic Diseases: A Nationwide Population-Based Dynamic Cohort Study in Taiwan. | Q36891825 | ||
| Kaposi's sarcoma: a model of both malignancy and chronic inflammation | Q36958659 | ||
| A comparison of the detection of BRCA mutation carriers through the provision of Jewish population-based genetic testing compared with clinic-based genetic testing | Q37081830 | ||
| Patient Navigation As a Model to Increase Participation of African Americans in Cancer Clinical Trials | Q37117883 | ||
| DNA methylation contributes to natural human variation | Q37138640 | ||
| Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence | Q37163880 | ||
| Associations between markers of colorectal cancer stem cells and adenomas among ethnic groups. | Q37278462 | ||
| Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium | Q37288681 | ||
| Genetic variants in microRNAs and breast cancer risk in African American and European American women | Q37376778 | ||
| Ethnic differences and functional analysis of MET mutations in lung cancer | Q37399540 | ||
| TERT promoter Mutation and Its Association with Clinicopathological Features and Prognosis of Papillary Thyroid Cancer: A Meta-analysis | Q37408393 | ||
| A 50-year review of colorectal cancer in African Americans: implications for prevention and treatment | Q37530697 | ||
| Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis | Q37543864 | ||
| Convergent evolution in European and Rroma populations reveals pressure exerted by plague on Toll-like receptors | Q37599857 | ||
| Cancer incidence among Asian American populations in the United States, 2009-2011. | Q37616452 | ||
| Racial disparities in Human Papillomavirus (HPV) associated head and neck cancer | Q37626550 | ||
| African Americans should be screened at an earlier age for colorectal cancer | Q37634134 | ||
| From evolutionary genetics to human immunology: how selection shapes host defence genes | Q37642585 | ||
| BRCA mutations and survival in breast cancer: an updated systematic review and meta-analysis | Q37688494 | ||
| Common breast cancer risk variants in the post-COGS era: a comprehensive review | Q37690575 | ||
| Tissue-specificity and ethnic diversity in obesity-related risk of cancer may be explained by variability in insulin response and insulin signaling pathways | Q37691234 | ||
| Relevance of single-nucleotide polymorphisms in human TLR genes to infectious and inflammatory diseases and cancer | Q38195472 | ||
| Racial/ethnic disparities in human DNA methylation | Q38228654 | ||
| A review of the Hispanic paradox: time to spill the beans? | Q38274916 | ||
| Black and White race differences in aerobic capacity, muscle fiber type, and their influence on metabolic processes | Q38367637 | ||
| Clinical impact of BRAF mutation on the diagnosis and prognosis of papillary thyroid carcinoma: a systematic review and meta-analysis | Q38663177 | ||
| MNX1 Is Oncogenically Upregulated in African-American Prostate Cancer | Q38734374 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 181-197 | |
| P577 | publication date | 2017-03-06 | |
| P1433 | published in | Trends in cancer | Q27726777 |
| P1476 | title | Racial Differences in Cancer Susceptibility and Survival: More Than the Color of the Skin? | |
| P478 | volume | 3 |
| Q92510255 | An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines |
| Q100697132 | Ethnic differences in mortality and hospital admission rates between Māori, Pacific, and European New Zealanders with type 2 diabetes between 1994 and 2018: a retrospective, population-based, longitudinal cohort study |
| Q91986815 | Genome-wide DNA methylation signatures to predict pathologic complete response from combined neoadjuvant chemotherapy with bevacizumab in breast cancer |
| Q98906809 | Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer |
| Q91216643 | Human papillomavirus as a driver of head and neck cancers |
| Q61799689 | Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients |
| Q90241844 | Mutation profiling of cancer drivers in Brazilian colorectal cancer |
| Q98199314 | Patterns of cancer family history and genetic counseling eligibility among African Americans with breast, prostate, lung, and colorectal cancers: A Detroit Research on Cancer Survivors cohort study |
| Q92503058 | Reporting of race in genome and exome sequencing studies of cancer: a scoping review of the literature |
| Q96132314 | Trends and clinicopathological characteristics of oral squamous cell carcinomas reported at a tertiary cancer hospital in Nepal during 1999 to 2009 |
Search more.